Biodel (BIOD)
Biodel Current Ratio: 11.82
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BIOD Current Ratio Rankings
| Overall | 96th percentile | 134 of 4373 |
| Sector | 92nd percentile | 37 of 503 in Healthcare |
| Industry | 84th percentile | 6 of 39 in Drug Manufacturers - Other |
BIOD Current Ratio Range, Past 5 Years
| Minimum | 4.625 | Dec 2010 |
| Maximum | 25.41 | Jun 2007 |
| Average | 10.36 |
About Current Ratio
The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. Current assets are cash and any assets expected to be converted into cash within the next year. The ratio illustrates a company's ability to remain solvent.
A current ratio of 1 means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning that it has twice as many current assets as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.
Learn More
You may also be interested in these BIOD related companies
BIOD News
$BIOD http://stks.co/3zVn 4HR view; 10 ready to cross 50, needs to break into the kumo
about 2 days ago by Tr8r_x
about 2 days ago by Tr8r_x
$BIOD http://stks.co/3yiM Battling the 200 day, 10, 50 & 200 converging
about 3 days ago by Tr8r_x
about 3 days ago by Tr8r_x
Biodel Announces Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
May 10, 3:32PM PR Newswire
May 10, 3:32PM PR Newswire
Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
May 07, 6:00AM PR Newswire
May 07, 6:00AM PR Newswire
$BIOD is being mentioned 23x the normal amount on Stocktwits 4,445.5% increase in mentions
about 31 days ago by TradeIdeas1
about 31 days ago by TradeIdeas1
$BIOD just hit $1...the strength that this stock has shown since Monday is incredible...Interesting to see how much it has left
about 31 days ago by investorgadget
about 31 days ago by investorgadget
@oliveblakcok speaking of pump $BIOD yea right LOL speaking of timber next i guess
about 32 days ago by biotech
about 32 days ago by biotech
$cycc too bad you keep pumping this crap...you could have been in $biod
about 32 days ago by oliveblakcok
about 32 days ago by oliveblakcok
Biodel to Provide Update on Stabilized Glucagon Program at ROTH Conference Today
Mar 14, 4:00PM PR Newswire
Mar 14, 4:00PM PR Newswire
Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012
Mar 08, 6:00AM PR Newswire
Mar 08, 6:00AM PR Newswire
Biodel to Report First Quarter Fiscal Year 2012 Financial Results on February 8, 2012
Feb 03, 6:59AM PR Newswire
Feb 03, 6:59AM PR Newswire
Biodel (BIOD) Gets Orphan Designation Suggestion from EMA COMP for CHI Treatment Glucagon
Jan 20, 7:04AM Street Insider
Jan 20, 7:04AM Street Insider
Biodel Inc. to Present at 30th Annual JPMorgan Healthcare Conference on January 12th, 2012
Jan 06, 6:59AM PR Newswire
Jan 06, 6:59AM PR Newswire
Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011
Dec 01, 4:00PM PR Newswire
Dec 01, 4:00PM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BIOD | 0.76 | +0.01 | +1.47% | 29.42M |
| BSI | 2.555 | +0.01 | +0.59% | 168.60M |
| BSFT | 25.65 | -0.51 | -1.95% | 704.35M |
| BSET | 9.48 | -0.22 | -2.27% | 106.84M |
| BSDM | 1.88 | -0.09 | -4.57% | 55.76M |
| BSD | 14.38 | -0.00 | -0.02% | |
| BSBR | 7.90 | +0.08 | +1.02% | 16.66B |
| BRY | 38.73 | +0.48 | +1.25% | 2.089B |
| BRT | 7.05 | +0.00 | +0.00% | 99.26M |
| BRS | 43.38 | -0.33 | -0.76% | 1.548B |
